PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 108 filers reported holding PROVENTION BIO INC in Q4 2020. The put-call ratio across all filers is 3.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,381,781 | +192.1% | 306,298 | +28.1% | 0.01% | +150.0% |
| Q4 2022 | $2,527,001 | +3616.2% | 239,073 | +1477.9% | 0.00% | – |
| Q3 2022 | $68,000 | +13.3% | 15,151 | +1.0% | 0.00% | – |
| Q2 2022 | $60,000 | -25.9% | 14,998 | +19.2% | 0.00% | – |
| Q3 2021 | $81,000 | -34.1% | 12,587 | -14.0% | 0.00% | – |
| Q2 2021 | $123,000 | -50.8% | 14,630 | -38.6% | 0.00% | – |
| Q1 2021 | $250,000 | -38.3% | 23,822 | -0.4% | 0.00% | – |
| Q4 2020 | $405,000 | +181.2% | 23,913 | +135.0% | 0.00% | – |
| Q2 2020 | $144,000 | – | 10,174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
| Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
| 683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
| Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
| GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
| Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
| Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
| Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |